High quality analysis of circulating biomarkers reveals no evidence of elevated inflammatory markers in a long COVID cohort recruited at a primary care center
Torres, M. L.; Lerma-Irureta, D.; Ibanez-Ruiz, J.; Lucas, A.; Magallon-Botaya, R.; Schoorlemmer, J.
Show abstract
Long COVID (LC) is a broad label encompassing the heterogeneous long-term consequences of SARSCoV2 infection that persist for at least 3 months post-infection. Despite its substantial global burden, there is still a lack of reliable biomarkers or panels capable of distinguishing individuals with Long COVID from healthy individuals or from those who have recovered from acute COVID-19. We previously characterized a biomarker panel comparing 85 adults with WHO-defined Long COVID against 85 age- and sex-matched controls who had recovered within three months of acute COVID-19 in 2020, at between 12 and 24 months post-infection. That initial profile evaluated blood cell counts, coagulation status, routine SARS-CoV-2 serology, immune cell populations, and basic cytokine levels based on Luminex assays. We have enhanced our biomarker panel by incorporating more precise cytokine quantification using the high-precision ELLA automated immunoassay system. To assess potential ongoing peripheral systemic inflammation, we measured classical inflammatory markers in blood, including C-reactive protein (CRP), tumor necrosis factor alpha (TNFalpha), interleukin (IL)1beta, and IL6. In this manuscript, we present data that confirm age- and gender-matching between the LC and control group; and compared differences in cytokine levels and comorbidities.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Persistent Autoimmune Activation and Proinflammatory State in Post-COVID Syndrome 95%
- Markers of immune activation and inflammation in individuals with post-acute sequelae of SARS-CoV-2 infection 94%
- Excessive matrix metalloproteinase-1 and hyperactivation of endothelial cells occurred in COVID-19 patients and were associated with the severity of COVID-19 94%
Similar papers in this journal
- Effects of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients 96%
- Assessment of oxidative stress markers in elderly patients with SARS-CoV-2 infection and potential prognostic implications. An observational study 94%
- SARS-CoV-2 antibody persistence after five and twelve months: A cohort study from South-Eastern Norway 94%
Similar papers in this journal
- Salivary detection of COVID-19. Clinical performance of oral sponge sampling for SARS-CoV-2 testing 93%
- Symptoms persisting after hospitalization for COVID-19: 12 months interim results of the COFLOW study 92%
- Limited recovery from post-acute sequelae of SARS-CoV-2 (PASC) at eight months in a prospective cohort 90%
Similar papers in this journal
Similar papers in this journal
- Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome (LTCS) patients 94%
- Blood transcriptomes of anti-SARS-CoV2 antibody positive healthy individuals with prior asymptomatic versus clinical infection 94%
- Exposing Limitations of Clinical Laboratory Tests in COVID-19 and the Promise of Immunological Biomarkers 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.